Liposomes—microscopic phospholipid bubbles with a bilayered membrane structure—have
received a lot of attention during the past 30 years as pharmaceutical carriers of great …

Currently used pharmaceutical nanocarriers, such as liposomes, micelles, nanoemulsions,
polymeric nanoparticles and many others demonstrate a broad variety of useful properties …

The paradigm of using nanoparticulate pharmaceutical carriers has been well established
over the past decade, both in pharmaceutical research and in the clinical setting. Drug …

The purpose of this expert review is to discuss the impact of nanotechnology in the treatment
of the major health threats including cancer, infections, metabolic diseases, autoimmune …

Liposomes, phospholipid vesicles with a bilayered membrane structure, have been widely
used as pharmaceutical carriers for drugs and genes, in particular for treatment of cancer. To …

The use of various pharmaceutical nanocarriers has become one of the most important
areas of nanomedicine. Ideally, such carriers should be specifically delivered (targeted) to …

Currently used pharmaceutical nanocarriers, such as liposomes, micelles, and polymeric
nanoparticles, demonstrate a broad variety of useful properties, such as longevity in the …

The purpose of this review is to provide an insight into the different aspects of pH‐sensitive
liposomes. The review consists of 6 parts: the first introduces different types of medications …

Since the discovery of liposomes, these phospholipid 'bubbles' have received enormous
attention to be recognized as 'smart'pharmaceutical nanocarriers. Recently, much effort has …

This review focuses on the application of drug-loaded nanoparticles (NPs), also called
therapeutic NPs, to combat cancer chemoresistance. Many cancer patients have …